Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health Autism

Brain imaging method detects genetic markers of autism with over 90% accuracy

by Eric W. Dolan
April 15, 2025
in Autism, Neuroimaging
[Adobe Stock]

[Adobe Stock]

Share on TwitterShare on Facebook
Stay on top of the latest psychology findings: Subscribe now!

A new study published in Science Advances introduces a powerful brain imaging technique that can detect autism-linked genetic variations with up to 95% accuracy. This approach, developed by researchers from multiple universities, including Johns Hopkins and Carnegie Mellon, analyzes structural brain images to identify specific genetic patterns associated with autism, potentially offering a way to detect the condition earlier and more objectively than current behavior-based methods.

Autism spectrum disorder is a neurodevelopmental condition characterized by differences in social communication, interaction, and the presence of restricted interests or repetitive behaviors. It is understood to result from a complex interplay of genetic predispositions and environmental influences. Currently, autism is diagnosed based on observing an individual’s behavior, a process that can take time and may not occur until certain developmental milestones are missed.

However, research increasingly points to a strong genetic component in autism. Understanding this genetic basis offers a potential pathway to better comprehend the condition’s origins, potentially leading to more personalized approaches and earlier support. This study explored a “genetics-first” avenue, focusing on specific genetic alterations known as copy number variations. These variations involve segments of a person’s genetic code being deleted or duplicated. Certain copy number variations are known to substantially increase the likelihood of developing autism.

The researchers aimed to see if unique patterns in brain structure, visible through imaging, could be directly linked to these specific genetic variations, providing a potential biological marker, sometimes called an endophenotype, that connects genes to observable traits.

To investigate this possibility, the research team, involving experts from Carnegie Mellon University, the University of California San Francisco, and the Johns Hopkins University School of Medicine, utilized a specialized computer modeling technique they developed called transport-based morphometry. This method stands apart from many other image analysis techniques because its mathematical underpinnings are based on modeling the movement and distribution of mass, akin to how substances move within biological tissues. It essentially quantifies the shape and form (morphometry) of the brain based on these modelled transport processes.

The researchers applied this technique to analyze brain scans from a group of 206 individuals sourced from the Simons Variation in Individuals Project. This cohort included 48 individuals with a deletion in a specific genetic region known as 16p11.2, 40 individuals with a duplication in the same region (both variations are strongly associated with increased autism risk), and 118 control participants without these specific genetic changes.

The control group was carefully selected to match the other participants in terms of age, sex, handedness, and non-verbal intelligence scores, and they were screened to exclude individuals with related neurological conditions or family histories of autism. High-resolution structural brain images (T1-weighted magnetic resonance imaging scans) were obtained for all participants using standardized procedures across different imaging sites.

The images underwent preprocessing steps to isolate brain tissue (gray matter and white matter), adjust for overall brain size differences, and normalize the data before the transport-based morphometry analysis was performed separately on gray matter and white matter distributions. The system was trained using machine learning principles to distinguish the brain structure patterns characteristic of the deletion group, the duplication group, and the control group.

The analysis revealed distinct patterns in brain structure associated with the 16p11.2 copy number variations. The transport-based morphometry system was highly effective at identifying which genetic group an individual belonged to based solely on their brain scan. When analyzing white matter structure, the system achieved an average accuracy of 94.6% in correctly classifying individuals into the deletion, duplication, or control group on previously unseen test data. Analyzing gray matter structure yielded an average accuracy of 88.5%. These results significantly outperformed classification attempts using only basic information like age, gender, or overall brain volume.

A key capability of the transport-based morphometry technique is that it is generative, meaning it allowed the researchers not just to classify the scans but also to visualize the specific brain structure differences driving the classifications. The analysis indicated that the 16p11.2 variations were associated with widespread, or diffuse, changes across the brain, rather than being confined to just one or two small areas.

There was a dose-dependent relationship observed: individuals with the 16p11.2 deletion tended to have larger overall brain volumes and relatively more gray matter tissue compared to controls, while those with the duplication tended to have smaller brain volumes and relatively less gray matter tissue. The visualization also revealed specific regional patterns.

For instance, areas involved in language processing, emotional regulation, visuospatial skills, and integrating information from multiple senses showed distinct patterns of relative tissue expansion or contraction depending on whether an individual had the deletion or duplication. Often, the effect was reciprocal, meaning a region might show relative expansion in the deletion group and relative contraction in the duplication group compared to controls. Some differences were also noted between the left and right sides of the brain.

Importantly, the researchers explored associations between these identified brain structure patterns and participants’ behavioral or cognitive characteristics. They found a strong association between one specific brain pattern (identified along what the researchers termed discriminant direction 1) and the presence of articulation disorders – difficulties producing speech sounds correctly.

This pattern was particularly prominent in individuals with the 16p11.2 deletion. Another distinct brain pattern (associated with discriminant direction 2) showed a significant association with participants’ intelligence quotient scores, explaining roughly 17-20% of the variation in full-scale, verbal, and nonverbal intelligence quotient measures across the groups. These findings suggest that the structural brain differences linked to the 16p11.2 copy number variations are related to observable functional outcomes.

The researchers acknowledge some limitations to their study. The participants were recruited through clinical genetics centers and patient networks, which might mean the sample doesn’t represent the full spectrum of individuals with these genetic variations, potentially missing those with milder or different presentations (ascertainment bias). The study focused on one specific genetic region, 16p11.2, and didn’t explore interactions with other genes.

While the study included individuals from childhood through adulthood, assuming relative stability of these brain patterns, further research focusing on early development is warranted. Also, while associations between brain structure patterns and behavioral measures like articulation or intelligence quotient were found, this type of study cannot establish a cause-and-effect relationship.

Future research could apply this transport-based morphometry approach to investigate other genetic variations linked to autism and related neurodevelopmental conditions. Larger studies involving more diverse populations and prospective studies tracking individuals over time are needed to validate these findings and explore their potential clinical utility for early detection, prognosis, or monitoring responses to interventions. Such work could significantly advance a genetics-first approach to understanding and supporting individuals with autism.

The study, “Discovering the gene-brain- behavior link in autism via generative machine learning,” was authored by Shinjini Kundu, Haris Sair, Elliott H. Sherr, Pratik Mukherjee, and Gustavo K. Rohde.

RELATED

Autism’s “odd gait”: Autistic movement differences linked to brain development
Autism

Autism’s “odd gait”: Autistic movement differences linked to brain development

August 27, 2025

Walking patterns may provide important insights into autism. Studies suggest autistic people often display distinctive gait differences, from slower steps to greater variability. These movement patterns link to brain development.

Read moreDetails
Rapid neuroplasticity changes are associated with ketamine treatment response in patients with depression
Dementia

Scientists achieve “striking” memory improvements by suppressing brain protein

August 27, 2025

Scientists have identified a brain protein that appears to drive age-related memory decline. In a new study, suppressing this protein in old mice led to gains in cognitive performance, offering insight into potential therapies for brain aging.

Read moreDetails
Scientists uncover biological pathway that could revolutionize anxiety treatment
MDMA

Psilocybin and MDMA may reset fear-related brain-immune signaling, scientists find

August 25, 2025

Psilocybin and MDMA may do more than alter perception. A study in Nature suggests they also reduce fear by targeting a newly identified immune-brain signaling loop, which becomes hyperactive under chronic stress and contributes to heightened fear responses.

Read moreDetails
Acetaminophen use during pregnancy linked to higher risk of autism, ADHD in children
ADHD

Acetaminophen use during pregnancy linked to higher risk of autism, ADHD in children

August 25, 2025

Researchers reviewed dozens of studies and found that children whose mothers used acetaminophen during pregnancy were more likely to be diagnosed with neurodevelopmental disorders. The study adds weight to growing concerns about the drug’s safety in pregnancy.

Read moreDetails
What we know about a person changes how our brain processes their face
Memory

Neuroscientists find evidence of an internal brain rhythm that orchestrates memory

August 24, 2025

A team of neuroscientists has observed that individual neurons in the human brain follow rhythmic timing patterns during memory tasks. The findings highlight how internal brain states influence when cells fire as people form and recall memories.

Read moreDetails
Women feel unsafe when objectified—but may still self-sexualize if the man is attractive or wealthy
Autism

A new frontier in autism research: predicting risk in babies as young as two months

August 23, 2025

Clinical trials are underway for an eye-tracking test that may predict autism in infancy, potentially revolutionizing early intervention. Yet the technology also poses difficult questions about medical ethics, parental decision-making, and how predictive data should be handled by insurers.

Read moreDetails
Study suggests that prefrontal cortex damage can have a paradoxical effect on rationality
Mental Health

Cerebellar-prefrontal brain connectivity may shape negative symptoms in psychosis

August 23, 2025

A new study supports the idea that reduced connectivity between the cerebellum and prefrontal cortex contributes to negative symptoms in psychosis. The findings may inform future treatments aimed at improving motivation, memory, and daily functioning.

Read moreDetails
Stress-induced “fixated” eating patterns linked to dopamine disruption, study finds
Addiction

Dopamine-boosting drug enhances self-control and reduces drinking in people with alcohol use disorder

August 22, 2025

A new study suggests the dopamine-boosting drug tolcapone may enhance self-control and reduce alcohol intake in people with alcohol use disorder by increasing activity in brain regions linked to inhibitory control, such as the inferior frontal gyrus and prefrontal cortex.

Read moreDetails

STAY CONNECTED

LATEST

New research shows people shift moral arguments to fit their stance on women’s bodies

Students whose parents were warmer towards them tend to have better socio-emotional skills

Scientists link immune markers to mental health symptoms in children with chronic illness

Even in secular Denmark, supernatural beliefs remain surprisingly common, study finds

A major new study charts the surprising ways people weigh AI’s risks and benefits

Study links phubbing sensitivity to attachment patterns in romantic couples

A common childhood virus could be silently fueling Alzheimer’s disease in old age

It’s not social media: What’s really fueling Trump shooting conspiracies might surprise you

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy